Corrigendum to “European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) [European Journal of Cancer 2024 (2024) 114062]” (European Journal of Cancer (2024) 204, (S0959804924007184), (10.1016/j.ejca.2024.114062))

The authors regret that in the Table “Recommendations for the definition of oligometastatic disease“ incompletely represented the proposed criteria, listing only “≤3 unilobar liver metastases” while omitting “≤2 bilobar liver metastases.” The correct definition of liver oligometastatic disease should include both: “≤3 unilobar liver metastases” or “≤2 bilobar liver metastases.” In addition, the same error appears in the main text, where the organ-specific definition of oligometastatic disease includes only “≤3 unilobar liver metastases,” omitting the criterion “≤2 bilobar liver metastases.” The correct definition of liver oligometastatic disease should encompass both: “≤3 unilobar liver metastases” or “≤2 bilobar liver metastases.” The authors would like to apologise for any inconvenience caused.